Does Co-administration of Lactate Affect Postprandial Nutrient Absorption and Fat Disposition?
Launched by UNIVERSITY OF AARHUS · Oct 30, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether taking lactate with meals can improve how the body absorbs nutrients and manages fat in people with pre-diabetes. The researchers believe that adding lactate might help reduce fat storage and improve the way the body handles fats after eating. This study is currently recruiting participants who are 50 years or older, have a specific range of blood sugar levels (known as HbA1c), and can give their consent to participate.
Eligible participants will be asked to take lactate with their meals and then will be monitored to see how their bodies respond. It's important to note that individuals who are taking certain medications that affect blood sugar or have recently changed their medications may not be eligible for this study. Participants should also be able to speak and understand Danish. This trial offers a chance to explore a new approach to managing pre-diabetes and may provide insights that could benefit others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 50+ years
- • Written and oral consent
- • HbA1c 39-47 mmol/L
- Exclusion Criteria:
- • Medicine with an impact on blood glucose and glucose metabolism.
- • Newly started medicine (\<3 months prior to the inclusion time)
- • Medicine changes (\<3 months prior to the inclusion time and planned changes during the trial)
- • Affected screening blood sample as evaluated by PI
- • Hba1c \> 47
- • Allergy to paracetamol
- • Doesn't speak or understand Danish
- • Special diets
- • The eight healthy individuals will be included by the same criteria except for not having pre-diabetes
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Patients applied
Trial Officials
Esben Søndergaard
Principal Investigator
Aarhus University, Steno Diabetes Center Aarhus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported